Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Xiankang Hu"'
Autor:
Yuzhou Xue, Minghao Luo, Xiankang Hu, Xiang Li, Jian Shen, Wenyan Zhu, Longxiang Huang, Yu Hu, Yongzheng Guo, Lin Liu, Lingbang Wang, Suxin Luo
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-16 (2022)
Characterisation of macrophages from human carotid artery plaques and in vitro assays reveal that macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through the IL-1β/STAT3 axis.
Externí odkaz:
https://doaj.org/article/9468f8782cd6410aa027a3dc8dd9524b
Publikováno v:
Frontiers in Psychology, Vol 12 (2022)
This study was conducted to investigate the relationship between posttraumatic growth (PTG), resilience, positive coping style, and self-efficacy among the primary caregivers of children with developmental disorders in Chongqing, China. A total of 19
Externí odkaz:
https://doaj.org/article/c38af6a603df48ec8d4a461ca7b73913
Autor:
Wuwan Wang, Xiankang Hu, Weitin Liao, W.H. Rutahoile, David J. Malenka, Xiaofang Zeng, Yunjing Yang, Panpan Feng, Li Wen, Wei Huang
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
No previous meta-analysis has evaluated the efficacy and safety of pulmonary vasodilators in Fontan physiology. Recent relative trials have obtained conflicting results regarding improvements in peak oxygen consumption; the relatively small number of
Externí odkaz:
https://doaj.org/article/eed3fbe3dad542498c9bba5e18e146fc
Autor:
Yi Jiang, Awadji Fabrice Boris, Yuansong Zhu, Hongbo Gan, Xiankang Hu, Yuzhou Xue, Zhenxian Xiang, Bryan Richard Sasmita, Gang Liu, Suxin Luo, Bi Huang
Publikováno v:
The American Journal of Cardiology. 167:20-26
The 2016 European Society of Cardiology Guidelines introduced a new term, mid-range left ventricular ejection fraction (mrEF) heart failure, however, the clinical characteristics and short-term outcomes in cardiogenic shock patients with mrEF after a
Publikováno v:
International Heart Journal. 62:742-751
Previous studies have indicated that low-dose new generation of P2Y12 receptor antagonists may be more suitable compared with clopidogrel at a standard dose for the dual antiplatelet therapy (DAPT) for East Asian patients receiving percutaneous coron
Autor:
Yuzhou Xue, Xiankang Hu, Bryan Richard Sasmita, Yuansong Zhu, Hongbo Gan, Zhenxian Xiang, Bi Huang, Gang Liu, Suxin Luo
Publikováno v:
Shock (Augusta, Ga.). 57(3)
Patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI) are at high risk of death. Inflammation is involved in both CS and AMI, and our present study aimed to investigate the changes of leukocyte and its subtypes as well a
Autor:
Yuansong Zhu, Bryan Richard Sasmita, Xiankang Hu, Yuzhou Xue, Hongbo Gan, Zhenxian Xiang, Yi Jiang, Bi Huang, Suxin Luo
Publikováno v:
International journal of clinical practice. 2022
Purpose. Cardiogenic shock (CS) is the leading cause of death in patients with acute myocardial infarction (AMI). Our study aimed to evaluate the short-term prognostic value of admission blood urea nitrogen (BUN) in patients with CS complicating AMI.
Autor:
Yuzhou Xue, Minghao Luo, Xiankang Hu, Xiang Li, Jian Shen, Wenyan Zhu, Longxiang Huang, Yu Hu, Yongzheng Guo, Lin Liu, Lingbang Wang, Suxin Luo
Publikováno v:
Communications biology. 5(1)
Vascular smooth muscle cells (VSMCs) play a central role in atherosclerosis progression, but the functional changes in VSMCs and the associated cellular crosstalk during atherosclerosis progression remain unknown. Here we show that scRNA-seq analysis
Autor:
Zhenxian Xiang, Xiankang Hu, Yuzhou Xue, Bryan Richard Sasmita, Hongbo Gan, Suxin Luo, Yuansong Zhu, Bi Huang
Publikováno v:
International Journal of Clinical Practice. 75
Cardiogenic shock (CS) is the most severe complication after acute myocardial infarction (AMI) with mortality above 50%. Inflammatory response is involved in the pathology of CS and AMI. In this study, we aimed to evaluate the prognostic value of adm
Publikováno v:
International heart journal. 62(4)
Previous studies have indicated that low-dose new generation of P2Y12 receptor antagonists may be more suitable compared with clopidogrel at a standard dose for the dual antiplatelet therapy (DAPT) for East Asian patients receiving percutaneous coron